Pharma success increasingly depends on proving value

05/15/2013 | PharmaTimes (U.K.)

A drug's success in the marketplace increasingly depends on the drugmaker's ability to prove value and additional benefit over existing pharmaceuticals, yet many drugmakers still take a blockbuster approach to development, an international survey by Camelot Management Consultants finds. Germany and the U.K. are among the nations linking reimbursement price to additional benefit, which drives pricing elsewhere.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA